Despite challenges such as high costs and access barriers, the demand for effective, tailored therapies continues to rise, transforming the psoriasis treatment landscapeDublin, Nov. 26, 2025 (GLOBE ...

The researchers’ findings suggest an increased prevalence of mental illness in people with eczema and psoriasis, but they found poor agreement in disease ascertainment settings. Consistent evidence ...

Investigators compared outcomes for severe mental illness between patients with both chronic skin conditions and healthy controls, using data from the UK Clinical Practice Research Datalink GOLD. A ...

For adults and adolescents with moderate-to-severe plaque psoriasis, selective blockade of the interleukin-23 receptor with the targeted oral peptide icotrokinra yields a significantly higher ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. AX-158 is a once-daily investigational oral, small ...

From acne to sunburns, your skin is vulnerable to a range of uncomfortable conditions. Among them is psoriasis, which often appears on the face and body and can have a negative impact on your quality ...

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in ...

DelveInsight's analysts estimate that the psoriasis market is poised to show significant growth, mainly attributed to increasing prevalence, recent drug approvals, and anticipated launch of novel ...

SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated Psoriasis Epidemiology Screening Tool (PEST) for psoriatic arthritis (PsA) ...